Health Research Programme Consortia (RPCS): Filling the Gaps in Evidence: Building Stronger and More Resilient Health Systems – Lot 2 (Equal)

Concepts

• research and development
• east kilbride
• fcdo
• health research programme consortia
• health research
• use of high quality evidence
• resilient health systems
• reproductive health
• global research efforts
• mental health

Location

East Kilbride

Description

The UK is seen as a leader in health research and a higher level of UK involvement will add value to global research efforts. FCDO (DFID) has committed to the production and use of high quality evidence, data and innovation to accelerate progress towards the Global Goals. The following areas were identified as being gaps and an opportunity for the UK to intervene, given our relative strengths: (i) tackling infectious diseases; (ii) building stronger and more resilient health systems; (iii) improving the health of the world’s most vulnerable, including sexual and reproductive health, mental health and maternal, newborn and child health.

Total Quantity or Scope

The goal of the Filling the Gaps in Evidence portfolio of RPCs is to produce high quality evidence that improves the health of the poorest and most vulnerable people in developing countries. The purpose of this component is to generate new knowledge on how to address marginalisation or exclusion of vulnerable groups. The UK is firmly committed to the ‘Leave no-one behind’ agenda. For development gains to be achieved, concerted efforts must be made to reach the poorest and most marginalised. Groups at risk may include people with disabilities, women, children and adolescents and conflict affected populations. Research submissions are expected to include a gender and disability lens i.e. how has the programme design taken into consideration how people with disabilities/men/women are impacted by the issue being researched? What are the different barriers they face? How will the research contribute to an evidence base on how to address these issues? An intersectional lens is critical to better understand the issues. Proposals can address any one or more of the following areas: • mental health; • sexual and reproductive health rights; • maternal and newborn child health; • improving health outcomes for vulnerable groups.

Award Detail

Renewal Options

There will be an option to extend for a further 24 months at an additional estimated value of GBP 2 000 000 — 3 000 000.

Award Criteria

CPV Codes

• 73000000 - Research and development services and related consultancy services

Indicators

• Options are available.
• Award on basis of price and quality.

Other Information

PO8397 was the tender process for a lotted procurement following the Reg 14 Research Exemption which resulted in 7 individual contracts across three lots, previous Contract Award Notice — OJ S: 2021/S 057-145367 provides the detail for 6 of these contracts (PO8610, PO8611, PO8612, PO8614. PO8615, PO8616 — with this Contract Award Notice solely for PO8613. In accordance with Regulation 14 of the Public Contracts Regulations 2015, the Regulations are not applicable to this procurement. The Procurement Process adopted by FCDO (ex DFID) is not to be construed as indicative of the application of the Public Contracts Regulations 2015. The use in this ITT of terms used in the Public Contracts Regulations 2015 or Directive 2014/24/EU should not be construed as implying the application of the relevant rules and jurisprudence of the Public Contracts Regulations 2015 or Directive 2014/24/EU to this procurement. Note: This contract opportunity is voluntarily published in the Official Journal of the European Union for publicity purposes only, and is not pursuant to the requirements of the Public Contracts Regulations 2015 or Directive 2014/24/EU. The services procured by this procurement process fall within CPV codes 73000000-2 (research and development services and related consultancy services) 73120000-9 (Experimental and development services), 73300000-5 (design and execution of research and development), 73420000-2 (pre feasibility study and technological demo) and 73430000 -5 (test and evaluation).